AVITA Medical, Inc. (RCEL) Selling and Marketing Expense USD 2018 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
AVITA Medical, Inc. quarterly/annual Selling and Marketing Expense history and growth rate from 2018 to 2024.
  • AVITA Medical, Inc. Selling and Marketing Expense for the quarter ending March 31, 2024 was $12.6 M, a 93.3% increase year-over-year.
  • AVITA Medical, Inc. Selling and Marketing Expense for the twelve months ending March 31, 2024 was $43.4 M, a 83.7% increase year-over-year.
  • AVITA Medical, Inc. annual Selling and Marketing Expense for 2023 was $37.3 M, a 70.2% increase from 2022.
  • AVITA Medical, Inc. annual Selling and Marketing Expense for 2022 was $21.9 M, a 49.5% increase from 2021.
  • AVITA Medical, Inc. annual Selling and Marketing Expense for 2021 was $14.7 M, a 6.66% decline from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $43.4 M $12.6 M +$6.1 M +93.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $37.3 M $10.2 M +$3.87 M +61.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $33.4 M $10.5 M +$5.12 M +94.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $28.3 M $10 M +$4.67 M +87.6% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $23.6 M $6.54 M +$1.71 M +35.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $21.9 M $6.34 M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $5.41 M +$1.89 M +53.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $5.33 M +$1.19 M +28.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $4.83 M +$1.18 M +32.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 $14.9 M $3.52 M +$253 K +7.75% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $14.7 M $4.15 M -$114 K -2.68% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $14.8 M $3.65 M -$726 K -16.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $15.5 M $3.6 M -$372 K -9.37% Oct 1, 2020 Dec 31, 2020 10-K 2021-08-26
Q3 2020 $15.9 M $3.27 M +$166 K +5.36% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $15.7 M $4.26 M +$319 K +8.09% Apr 1, 2020 Jun 30, 2020 10-K 2021-08-26
Q1 2020 $15.4 M $4.38 M +$1.07 M +32.2% Jan 1, 2020 Mar 31, 2020 10-K 2021-08-26
Q4 2019 $14.3 M $3.97 M +$1.13 M +39.9% Oct 1, 2019 Dec 31, 2019 10-K 2021-08-26
Q3 2019 $13.2 M $3.1 M +$936 K +43.3% Jul 1, 2019 Sep 30, 2019 10-K 2021-08-26
Q2 2019 $12.3 M $3.94 M Apr 1, 2019 Jun 30, 2019 10-K 2020-08-27
Q1 2019 $3.31 M Jan 1, 2019 Mar 31, 2019 10-K 2020-08-27
Q4 2018 $2.84 M Oct 1, 2018 Dec 31, 2018 10-K 2020-08-27
Q3 2018 $2.16 M Jul 1, 2018 Sep 30, 2018 10-K 2020-08-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.